Top Gold Stock OR Royalties Hits 80-Plus RS Rating | Investor's Business Daily BREAKING: Futures Fall After Stocks Pare Gains Gold stock OR Royalties (OR) rose to a record high 48.06 on Feb. 27 as the amazing run for the price of gold continued. The price of gold slid this month, taking a bite out of top-rated OR Gold with it. Monday No. 1 rated OR Royalties rose 4.5%. And it edged out a small gain on Tuesday. Additionally, on Tuesday OR stock got a Relative Strength (RS) Ratingupgrade to 83, up from 80 on ...

Virtu Financial Stock Earns 83 RS Rating | Investor's Business Daily BREAKING: Futures Rise, Oil Prices Fall On Iran Deal Hopes Virtu Financial (VIRT) stock saw a positive improvement to its Relative Strength (RS) Ratingon Monday, rising from 75 to 83. X Reading Between The Lines: How To Watch For Market Turns Through News Coverage See All Videos NOW PLAYING Reading Between The Lines: How To Watch For Market Turns Through News Coverage Over 100 years of market history reveals that the market's biggest winne ...

Burger King Parent In Buy Zone, Gets Rating Upgrade | Investor's Business Daily TRENDING: Biotechs Breathe Easy As FDA Vaccine Chief Plans Exit. But Should They? Burger King and Tim Hortons' parent Restaurant Brands International (QSR) recently broke out of a flat base on strong earnings, and it's in a buy zone. On Monday, the restaurant stock rose to the highest price since July 2024. Also on Monday, the highly rated stock got a Relative Strength (RS) Ratingupgrade to 73, up from 70 on Friday. The 73 RS Ra ...

Core Insights - Brink's has achieved an 83 Relative Strength (RS) Rating, indicating strong market leadership and placing it in the top 17% of stocks for price performance over the last 52 weeks [1] - The company reported a 20% increase in earnings per share (EPS) to $2.54 and a 9% rise in sales to $1.38 billion [1] - Brink's stock has shown significant growth, breaking out of a flat base with a buy point of 118.60 on December 11, and reaching an all-time high at the end of February [1] Financial Performance - EPS grew by 20% to $2.54 per share [1] - Sales increased by 9% to $1.38 billion [1] - Brink's holds a 95 EPS Rating out of 99, indicating strong earnings performance [1] Market Position - Brink's has an 85 Composite Rating, placing it in the top 15% of stocks based on fundamental and technical metrics [1] - The company ranks No. 6 among its peers in the 47-stock Security/Safety industry group [1] - Other top-rated stocks in the group include Cadre Holdings, NAPCO Security Techs, and APi Group [1] Stock Performance - The stock rose nearly 5% on the day of the earnings report and an additional 7.8% the following Monday [1] - Brink's stock traded around 125 on Tuesday afternoon following the recent market turmoil [1] - The B Accumulation/Distribution Rating indicates that funds are buying more shares than selling [1]

Core Viewpoint - Halozyme Therapeutics is highlighted as a stock to watch, nearing a buy point with a focus on its technical analysis patterns, particularly the double bottom pattern, which is considered a positive indicator for potential investment [1]. Group 1: Stock Performance - Halozyme Therapeutics (HALO) is currently priced at $75.36, showing an increase of $0.91 or 1.22% [1]. - The stock has a composite rating of 99 out of 99, indicating strong performance relative to its peers [1]. - The company is ranked 8th out of 197 in its industry group, showcasing its competitive position [1]. Group 2: Technical Analysis - The stock is approaching a buy point at $75.59, which is identified as a critical entry point for investors [1]. - The emerging pattern of a double bottom is noted as one of the three positive chart patterns to look for in technical analysis [1]. - Halozyme's relative strength rating has seen an upgrade, indicating improved performance compared to the market [1].

Core Viewpoint - LivaNova is experiencing a unique base formation with a flat base buy point of $65.57, indicating potential upward movement driven by new opportunities in the market [1]. Group 1: Stock Performance - LivaNova's stock price is currently at $64.06, reflecting a slight increase of $0.03 or 0.05% [1]. - The company has shown a relative strength rating improvement to 76, indicating rising relative price strength [1]. - LivaNova has a composite rating of 95 out of 99, positioning it favorably within its industry [1]. Group 2: Market Context - The stock is part of a broader market context where the S&P 500 is hitting all-time highs and is poised to reach the 7,000 level, as the market anticipates a significant earnings season [1]. - LivaNova is highlighted among stocks with rising relative price strength and composite ratings, suggesting strong market interest and potential for growth [1].

Group 1 - Exelixis has formed a cup-with-handle pattern since June, with a buy point at 44.91, and its stock is currently trading around 43, indicating it is approaching a breakout point from this base [5] - Exelixis has achieved a Composite Rating of 96, placing it in the top 4% of stocks overall, reflecting strong fundamentals [5] - The company's Relative Strength Rating has been upgraded from 76 to 81, indicating rising price performance [6] Group 2 - Exelixis has seen its Composite Rating rise to 97, further demonstrating its strong market position [8] - The stock is noted for its rising relative strength, making it a focus for investors [10] - Other stocks like Ligand Pharmaceuticals and Liquidia have also received upgrades in their Relative Strength Ratings, indicating a positive trend in the biotech sector [10]

Group 1 - Nasdaq leads the market as stocks open higher, with gold and silver prices rising, benefiting mining and gold stocks [1] - Enova International (ENVA) and Ero Copper (ERO) reached record highs, identified by IBD's Screen Of The Day for their strong relative strength [1] - Ero Copper reported a significant 156% increase in profits last quarter, leading to a key rating upgrade and an improvement in its relative strength rating to 79 [4] Group 2 - Enova International achieved a composite rating improvement to 96, meeting over 80 relative strength rating benchmarks [4] - The stock market is showing multifaceted strength with new highs, raising questions about which sectors can outperform industry leaders [4]

Core Insights - Option Care Health (OPCH) is experiencing significant stock performance, with a Composite Rating of 96, placing it in the top 4% of stocks overall [1] - The company has demonstrated strong fundamentals, achieving double-digit sales and profit growth every quarter over the past year [1] Stock Performance - Option Care's Relative Strength Rating improved from 66 to 74, indicating it outperforms over 70% of stocks in price performance over the last 52 weeks [2] - The stock traded at $24.23 on October 30 and surged to around $31, marking a 28% increase within one month [4] Financial Metrics - The company reported a 10% earnings growth last quarter, reaching $0.45 per share, while revenue increased by 12% to $1.44 billion [5] - Option Care holds an 87 EPS Rating and a strong SMR Rating of B, alongside an A Accumulation/Distribution Rating, indicating strong institutional buying interest [3] Industry Position - Option Care Health ranks No. 3 among its peers in the Medical-Services industry group, which consists of 39 stocks [5] - The company is attempting to complete a consolidation phase with a buy point at $35.53, aiming for a breakout with volume at least 40% above average [5]

Group 1 - Amer Sports, the parent company of brands like Arcteryx and Wilson, received an upgrade in its Relative Strength (RS) Rating from 61 to 74, indicating strong performance in its industry [1] - The stock of Amer Sports increased by 4.6% following the rating upgrade, positioning it as the top performer in its industry group [1] - Amer Sports' Composite Rating has risen to 97, reflecting its strong price performance and market position [3] Group 2 - The overall market sentiment is bullish, with the Dow hitting a record high, influenced by a speech from Powell [3] - Other companies such as Nvidia and Broadcom are also in focus as the market undergoes significant shifts [3] - Upcoming earnings reports from Walmart, Viking, and Amer Sports are anticipated to provide insights into the strength of the U.S. economy [3]